Schedule 13D ownership disclosure

VOR BIOPHARMA INC

Security class unavailable · CUSIP: 929033108

Event date: 2022-11-10

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
11,131,300
Percent of class
28.7800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-22-118679
Form type
SC 13D/A
Filer
RA CAPITAL MANAGEMENT, L.P.
CIK
CIK 1346824
Filed
Nov 14, 2022
Reporting period
Nov 10, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub